Browsing by Author "Papandreou, C."
Now showing items 1-9 of 9
-
Alterations of microRNAs in solid cancers and their prognostic value
Chira, P.; Vareli, K.; Sainis, I.; Papandreou, C.; Briasoulis, E. (2010)MicroRNAs (miRNAs) are evolutionarily conserved, naturally abundant, small, regulatory non-coding RNAs that inhibit gene expression at the post-transcriptional level in a sequence-specific manner. Each miRNA represses the ... -
Effect of ET-1, FGF-2, and HGF on intracellular steroidogenesis in prostate cancer cells
Vasileiou, C.; Hatzidaki, E.; Karkabounas, A.; Maragkouli, E.; Vaiou, M.; Dimas, K.; Liakos, P.; Lekka, M.; Papandreou, C. (2013) -
Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer
Mitrakas, L.; Gravas, S.; Karasavvidou, F.; Dimakopoulos, G.; Moutzouris, G.; Tzortzis, V.; Koukoulis, G.; Papandreou, C.; Melekos, M. (2015)Endothelin-1 (ET-1) is a multifunctional peptide exerting its effects via receptors A and B. ET-1 and its receptors, endothelin axis (ET axis), play a promoting role in cancer biology. Alterations of proteins of ET axis ... -
Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association study and meta-analysis
Zintzaras, E.; Grammatikou, M.; Kitsios, G. D.; Doxani, C.; Zdoukopoulos, N.; Papandreou, C. (2010)The endothelial nitric oxide synthase gene (NOS3) has been proposed as a candidate gene for breast cancer (BC), however, the specific role of variants and haplotypes has not been clarified. We examined the association of ... -
Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer
Bamias, A.; Karadimou, A.; Lampaki, S.; Aravantinos, G.; Xanthakis, I.; Papandreou, C.; Lainakis, G.; Zagouri, F.; Soupos, N.; Kostouros, E.; Samantas, E.; Hatzimouratidis, C.; Konstantinidis, C.; Deliveliotis, C.; Pectasides, D. G.; Fountzilas, G.; Dimopoulos, M. A.; Hellenic Cooperative Oncology, Grp (2011) -
Prostate cancer: ESMO consensus conference guidelines 2012
Horwich, A.; Hugosson, J.; de reijke, T.; Wiegel, T.; Fizazi, K.; Kataja, V.; Parker, C.; Bellmunt, J.; Berthold, D.; Bill-axelson, A.; Carlsson, S.; Daugaard, G.; De meerleer, G.; De reijke, T.; Dearnaley, D.; Fonteyne, V.; Gillessen, S.; Heinrich, D.; Kwiatkowski, M.; Nilsson, S.; Padhani, A.; Papandreou, C.; Roobol, M.; Sella, A.; Valdagni, R.; Van der kwast, T.; Verhagen, P. (2013)The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological ... -
Revisiting bleomycin from pathophysiology to safe clinical use
Froudarakis, M.; Hatzimichael, E.; Kyriazopoulou, L.; Lagos, K.; Pappas, P.; Tzakos, A. G.; Karavasilis, V.; Daliani, D.; Papandreou, C.; Briasoulis, E. (2013)Bleomycin is a key component of curative chemotherapy regimens employed in the treatment of curable cancers, such as Hodgkin lymphoma (HL) and testicular germ-cell tumours (GCT), yet its use may cause bleomycin-induced ... -
Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: A focus beyond ejaculation disorders
Dimitropoulos, K.; Karatzas, A.; Papandreou, C.; Daliani, D.; Zachos, I.; Pisters, L. L.; Tzortzis, V. (2015)Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) represents an integral part of multidisciplinary treatment of advanced germ cell cancer; however, it is associated with a high complications rate. The ... -
Simple and Reliable HPLC Method for the Monitoring of Methotrexate in Osteosarcoma Patients
Begas, E.; Papandreou, C.; Tsakalof, A.; Daliani, D.; Papatsibas, G.; Asprodini, E. (2014)Methotrexate (MTX) is a dihydrofolate reductase inhibitor that is used for the treatment of tumors and autoimmune diseases. Several automated binding assays are used in clinical practice and numerous chromatographic methods ...